$2.99 -0.04 (-1.32%)
2/13/2012 4:00 PM

Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Recs

1
Player Avatar fiordwalker (43.03) Submitted: 3/25/2008 3:23:03 PM : Outperform Start Price: $10.44 OREX Score: -75.16

weight loss drug could be a blockbuster

Report this Post Add Comment

Featured Broker Partners


Advertisement